Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 12735
TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724231BDBM724231(US20250066345, Compound I-25)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724232BDBM724232(US20250066345, Compound I-39)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724229BDBM724229(US20250066345, Compound I-23)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724230BDBM724230(US20250066345, Compound I-24)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724225BDBM724225(US20250066345, Compound I-17)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724226BDBM724226(US20250066345, Compound I-18)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724240BDBM724240(US20250066345, Compound I-48)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724235BDBM724235(US20250066345, Compound I-42)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724233BDBM724233(US20250066345, Compound I-40)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724234BDBM724234(US20250066345, Compound I-41)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724215BDBM724215(US20250066345, Compound I-7)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724216BDBM724216(US20250066345, Compound I-8)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724213BDBM724213(US20250066345, Compound I-5)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724214BDBM724214(US20250066345, Compound I-6)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724211BDBM724211(US20250066345, Compound I-3)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724243BDBM724243(US20250066345, Compound I-51)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724212BDBM724212(US20250066345, Compound I-4)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724209BDBM724209(US20250066345, Compound I-1)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724241BDBM724241(US20250066345, Compound I-49)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724210BDBM724210(US20250066345, Compound I-2)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724224BDBM724224(US20250066345, Compound I-16)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724221BDBM724221(US20250066345, Compound I-13)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724220BDBM724220(US20250066345, Compound I-12)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724242BDBM724242(US20250066345, Compound I-50)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724222BDBM724222(US20250066345, Compound I-14)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724219BDBM724219(US20250066345, Compound I-11)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724217BDBM724217(US20250066345, Compound I-9)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724227BDBM724227(US20250066345, Compound I-19)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724228BDBM724228(US20250066345, Compound I-22)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724239BDBM724239(US20250066345, Compound I-47)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724223BDBM724223(US20250066345, Compound I-15)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724237BDBM724237(US20250066345, Compound I-45)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724238BDBM724238(US20250066345, Compound I-46)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724236BDBM724236(US20250066345, Compound I-43)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 724218BDBM724218(US20250066345, Compound I-10)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
US Patent